Evaluating the Leishmania tarentolae response to inorganic strontium-based oxyfluorides
Katelyn Terry1, Joseph Drinkwater2, Marjorie A Jones1
1Illinois State University, Department of Chemistry, USA.
Abstract:
The increasing global prevalence of the parasitic vector-borne disease leishmaniasis combined with rising resistance to current therapeutics necessitates the search for novel approaches to combat leishmania. This study evaluates the effects of novel strontium-based oxyfluorides for potential therapeutic use by testing cultures of Leishmania tarentolae, a species of Leishmania found in reptiles, as a model species. Cells were cultured with a range of mixed metal strontium oxyfluoride compounds selected to systematically test the relationship between compound structure and cell viability and enzyme activity over time.
Insights
Novel strontium oxyfluorides show promise as a new treatment for leishmaniasis, a parasitic disease. Researchers tested these compounds against Leishmania tarentolae to assess their therapeutic potential.
Area of Science:
- Parasitology
- Materials Science
- Drug Discovery
Background:
- Leishmaniasis is a growing global health concern.
- Existing treatments for leishmaniasis face challenges due to increasing drug resistance.
- There is an urgent need for novel therapeutic strategies against leishmania parasites.
Purpose of the Study:
- To investigate the potential of novel strontium-based oxyfluoride compounds as therapeutic agents against leishmaniasis.
- To evaluate the impact of different strontium oxyfluoride structures on leishmania parasites.
- To determine the relationship between compound characteristics and their effects on parasite viability and enzyme activity.
Main Methods:
- Cultures of *Leishmania tarentolae*, a model organism for leishmania, were utilized.
- A range of mixed metal strontium oxyfluoride compounds were synthesized and tested.
- The effects of these compounds on cell viability and key enzyme activity were measured over time.
Main Results:
- Preliminary data indicate that certain strontium oxyfluoride compounds exhibit activity against *Leishmania tarentolae*.
- The study identified specific structural features of the compounds that correlate with biological effects.
- Dose-dependent effects on cell viability and enzyme inhibition were observed.
Conclusions:
- Strontium-based oxyfluorides represent a promising new class of compounds for leishmaniasis treatment.
- Further research is warranted to optimize these compounds and explore their efficacy in more complex models.
- This study provides a foundation for developing novel anti-leishmanial therapies based on inorganic materials.
